Heterogeneity in predicting the future impact of technologies to control hepatocellular carcinoma (HCC) : a comparison of stakeholder views from Europe and Asia

J. F. Bridges; G. Gallego; S. M. Joy; B. M. Blauvelt

doi:10.1016/j.jval.2011.08.017

Heterogeneity in predicting the future impact of technologies to control hepatocellular carcinoma (HCC) : a comparison of stakeholder views from Europe and Asia

J. F. Bridges
, G. Gallego
, S. M. Joy
, B. M. Blauvelt

Research output: Chapter in Book / Conference Paper › Conference Paper › peer-review

Abstract

Hepatocellular carcinoma (HCC) is both common and deadly; yet predicting the future impact of technologies is difficult. We studied opinions about the potential impact of HCC-control technologies over a 5-10 year horizon and compared results from Europe and Asia.

Original language	English
Title of host publication	Value in Health. Vol. 14, No. 7. ISPOR 14th Annual European Congress Research Abstracts: 5-8 November 2011, Hotel Auditorium, Madrid, Spain
Publisher	Elsevier
Pages	A234-A234
Number of pages	1
DOIs	https://doi.org/10.1016/j.jval.2011.08.017
Publication status	Published - 2011
Event	ISPOR European Congress - Duration: 1 Jan 2011 → …

Conference

Conference	ISPOR European Congress
Period	1/01/11 → …

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1016/j.jval.2011.08.017

Cite this

Bridges, J. F., Gallego, G., Joy, S. M., & Blauvelt, B. M. (2011). Heterogeneity in predicting the future impact of technologies to control hepatocellular carcinoma (HCC) : a comparison of stakeholder views from Europe and Asia. In Value in Health. Vol. 14, No. 7. ISPOR 14th Annual European Congress Research Abstracts: 5-8 November 2011, Hotel Auditorium, Madrid, Spain (pp. A234-A234). Elsevier. https://doi.org/10.1016/j.jval.2011.08.017

Bridges, J. F. ; Gallego, G. ; Joy, S. M. et al. / Heterogeneity in predicting the future impact of technologies to control hepatocellular carcinoma (HCC) : a comparison of stakeholder views from Europe and Asia. Value in Health. Vol. 14, No. 7. ISPOR 14th Annual European Congress Research Abstracts: 5-8 November 2011, Hotel Auditorium, Madrid, Spain. Elsevier, 2011. pp. A234-A234

@inproceedings{2bfac42e743d4de9a3b17c994d63c4d3,

title = "Heterogeneity in predicting the future impact of technologies to control hepatocellular carcinoma (HCC) : a comparison of stakeholder views from Europe and Asia",

abstract = "Hepatocellular carcinoma (HCC) is both common and deadly; yet predicting the future impact of technologies is difficult. We studied opinions about the potential impact of HCC-control technologies over a 5-10 year horizon and compared results from Europe and Asia.",

author = "Bridges, \{J. F.\} and G. Gallego and Joy, \{S. M.\} and Blauvelt, \{B. M.\}",

year = "2011",

doi = "10.1016/j.jval.2011.08.017",

language = "English",

pages = "A234--A234",

booktitle = "Value in Health. Vol. 14, No. 7. ISPOR 14th Annual European Congress Research Abstracts: 5-8 November 2011, Hotel Auditorium, Madrid, Spain",

publisher = "Elsevier",

note = "ISPOR European Congress ; Conference date: 01-01-2011",

}

Bridges, JF, Gallego, G, Joy, SM & Blauvelt, BM 2011, Heterogeneity in predicting the future impact of technologies to control hepatocellular carcinoma (HCC) : a comparison of stakeholder views from Europe and Asia. in Value in Health. Vol. 14, No. 7. ISPOR 14th Annual European Congress Research Abstracts: 5-8 November 2011, Hotel Auditorium, Madrid, Spain. Elsevier, pp. A234-A234, ISPOR European Congress, 1/01/11. https://doi.org/10.1016/j.jval.2011.08.017

Heterogeneity in predicting the future impact of technologies to control hepatocellular carcinoma (HCC) : a comparison of stakeholder views from Europe and Asia. / Bridges, J. F.; Gallego, G.; Joy, S. M. et al.
Value in Health. Vol. 14, No. 7. ISPOR 14th Annual European Congress Research Abstracts: 5-8 November 2011, Hotel Auditorium, Madrid, Spain. Elsevier, 2011. p. A234-A234.

Research output: Chapter in Book / Conference Paper › Conference Paper › peer-review

TY - GEN

T1 - Heterogeneity in predicting the future impact of technologies to control hepatocellular carcinoma (HCC) : a comparison of stakeholder views from Europe and Asia

AU - Bridges, J. F.

AU - Gallego, G.

AU - Joy, S. M.

AU - Blauvelt, B. M.

PY - 2011

Y1 - 2011

N2 - Hepatocellular carcinoma (HCC) is both common and deadly; yet predicting the future impact of technologies is difficult. We studied opinions about the potential impact of HCC-control technologies over a 5-10 year horizon and compared results from Europe and Asia.

AB - Hepatocellular carcinoma (HCC) is both common and deadly; yet predicting the future impact of technologies is difficult. We studied opinions about the potential impact of HCC-control technologies over a 5-10 year horizon and compared results from Europe and Asia.

UR - http://handle.uws.edu.au:8081/1959.7/535531

U2 - 10.1016/j.jval.2011.08.017

DO - 10.1016/j.jval.2011.08.017

M3 - Conference Paper

SP - A234-A234

BT - Value in Health. Vol. 14, No. 7. ISPOR 14th Annual European Congress Research Abstracts: 5-8 November 2011, Hotel Auditorium, Madrid, Spain

PB - Elsevier

T2 - ISPOR European Congress

Y2 - 1 January 2011

ER -

Bridges JF, Gallego G, Joy SM, Blauvelt BM. Heterogeneity in predicting the future impact of technologies to control hepatocellular carcinoma (HCC) : a comparison of stakeholder views from Europe and Asia. In Value in Health. Vol. 14, No. 7. ISPOR 14th Annual European Congress Research Abstracts: 5-8 November 2011, Hotel Auditorium, Madrid, Spain. Elsevier. 2011. p. A234-A234 doi: 10.1016/j.jval.2011.08.017

Heterogeneity in predicting the future impact of technologies to control hepatocellular carcinoma (HCC) : a comparison of stakeholder views from Europe and Asia

Abstract

Conference

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this